Phase Ia Clinical Study of HDM1005 Injection
NCT06640647
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
65
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity and Overweight
Interventions
DRUG:
HDM1005 injection or placebo
Sponsor
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.